Shopping Cart 0
Cart Subtotal
USD 0

Elite Pharmaceuticals Inc (ELTP) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Elite Pharmaceuticals Inc (ELTP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company's operations and business divisions.

- Corporate strategy - Analyst's summarization of the company's business strategy.

- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history - Progression of key events associated with the company.

- Major products and services - A list of major products, services and brands of the company.

- Key competitors - A list of key competitors to the company.

- Key employees - A list of the key executives of the company.

- Executive biographies - A brief summary of the executives' employment history.

- Key operational heads - A list of personnel heading key departments/functions.

- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities - A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Elite Pharmaceuticals Inc (Elite) is a specialty pharmaceutical company focuses on the development of oral sustained and controlled release drug products. The company manufactures and develops generic drugs with Abbreviated New Drug Applications (ANDA) and branded drugs with New Drug Application (NDA) for the treatment of pain, obesity, hypertension, depression, infection and allergy, among others. Elite also has a pipeline of abuse-deterrent opioids for the treatment of chronic pain. The company uses its proprietary ART (abuse-deterrent technology) platform to develop and manufacture oral, controlled-release drugs. Elite is headquartered in Northvale, New Jersey, the US.

Elite Pharmaceuticals Inc Key Recent Developments

Aug 09,2018: Elite Pharmaceuticals reports financial results for the first quarter of fiscal year 2019 ended June 30, 2018

Aug 07,2018: Elite Pharmaceuticals appoints Aqeel A. Fatmi to its Board of Directors

Jun 14,2018: Elite Pharmaceuticals Announces Financial Results for the Fiscal Year Ended March 31, 2018

Feb 09,2018: Elite Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2018 Ended December 31, 2017

Jan 10,2018: Elite Pharmaceuticals Reports Positive Topline Results from Pivotal Bioequivalence Studies for an Extended-Release Generic

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 - About the Company 6

Elite Pharmaceuticals Inc - Key Facts 6

Elite Pharmaceuticals Inc - Key Employees 7

Elite Pharmaceuticals Inc - Key Employee Biographies 8

Elite Pharmaceuticals Inc - Major Products and Services 9

Elite Pharmaceuticals Inc - History 11

Elite Pharmaceuticals Inc - Company Statement 14

Elite Pharmaceuticals Inc - Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Section 2 - Company Analysis 16

Company Overview 16

Elite Pharmaceuticals Inc - Business Description 17

Business Segment: Branded Pharmaceuticals (NDA segment) 17

Overview 17

Performance 17

Business Segment: Generic Pharmaceuticals (ANDA segment) 17

Overview 17

Performance 17

R&D Overview 17

Elite Pharmaceuticals Inc - Corporate Strategy 19

Elite Pharmaceuticals Inc - SWOT Analysis 20

SWOT Analysis - Overview 20

Elite Pharmaceuticals Inc - Strengths 20

Elite Pharmaceuticals Inc - Weaknesses 21

Elite Pharmaceuticals Inc - Opportunities 22

Elite Pharmaceuticals Inc - Threats 23

Elite Pharmaceuticals Inc - Key Competitors 24

Section 3 - Company Financial Ratios 25

Financial Ratios - Capital Market Ratios 25

Financial Ratios - Annual Ratios 26

Performance Chart 29

Financial Performance 29

Financial Ratios - Interim Ratios 30

Financial Ratios - Ratio Charts 31

Section 4 - Company's Lifesciences Financial Deals and Alliances 32

Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32

Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 33

Elite Pharmaceuticals Inc, Recent Deals Summary 34

Section 5 - Company's Recent Developments 35

Aug 09, 2018: Elite Pharmaceuticals reports financial results for the first quarter of fiscal year 2019 ended June 30, 2018 35

Aug 09, 2018: Elite Pharmaceuticals reports financial results for the first quarter of fiscal year 2019 ended June 30, 2018 36

Aug 09, 2018: Elite Pharmaceuticals reports financial results for the first quarter of fiscal year 2019 ended June 30, 2018 37

Aug 09, 2018: Elite Pharmaceuticals reports financial results for the first quarter of fiscal year 2019 ended June 30, 2018 38

Aug 09, 2018: Elite Pharmaceuticals reports financial results for the first quarter of fiscal year 2019 ended June 30, 2018 39

Aug 07, 2018: Elite Pharmaceuticals appoints Aqeel A. Fatmi to its Board of Directors 40

Aug 07, 2018: Elite Pharmaceuticals appoints Aqeel A. Fatmi to its Board of Directors 41

Aug 07, 2018: Elite Pharmaceuticals appoints Aqeel A. Fatmi to its Board of Directors 42

Feb 09, 2018: Elite Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2018 Ended December 31, 2017 43

Jan 10, 2018: Elite Pharmaceuticals Reports Positive Topline Results from Pivotal Bioequivalence Studies for an Extended-Release Generic 44

Section 6 - Appendix 45

Methodology 45

Ratio Definitions 45

About GlobalData 49

Contact Us 49

Disclaimer 49


List Of Figure

List of Figures

Elite Pharmaceuticals Inc, Performance Chart (2014 - 2018) 29

Elite Pharmaceuticals Inc, Ratio Charts 31

Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32

Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 33


List Of Table

List of Tables

Elite Pharmaceuticals Inc, Key Facts 6

Elite Pharmaceuticals Inc, Key Employees 7

Elite Pharmaceuticals Inc, Key Employee Biographies 8

Elite Pharmaceuticals Inc, Major Products and Services 9

Elite Pharmaceuticals Inc, History 11

Elite Pharmaceuticals Inc, Subsidiaries 15

Elite Pharmaceuticals Inc, Key Competitors 24

Elite Pharmaceuticals Inc, Ratios based on current share price 25

Elite Pharmaceuticals Inc, Annual Ratios 26

Elite Pharmaceuticals Inc, Annual Ratios (Cont...1) 27

Elite Pharmaceuticals Inc, Annual Ratios (Cont...2) 28

Elite Pharmaceuticals Inc, Interim Ratios 30

Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32

Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 33

Elite Pharmaceuticals Inc, Recent Deals Summary 34

Currency Codes 45

Capital Market Ratios 45

Equity Ratios 46

Profitability Ratios 46

Cost Ratios 47

Liquidity Ratios 47

Leverage Ratios 48

Efficiency Ratios 48

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Elite Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Sandoz Inc

Purdue Pharma LP

Par Pharmaceutical Holdings Inc

Pain Therapeutics Inc

Mylan Laboratories Ltd

DURECT Corp

Collegium Pharmaceutical Inc

Allergan Plc

Acura Pharmaceuticals Inc

Elite Pharmaceuticals Inc (ELTP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company's operations and business divisions.

- Corporate strategy - Analyst's summarization of the company's business strategy.

- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history - Progression of key events associated with the company.

- Major products and services - A list of major products, services and brands of the company.

- Key competitors - A list of key competitors to the company.

- Key employees - A list of the key executives of the company.

- Executive biographies - A brief summary of the executives' employment history.

- Key operational heads - A list of personnel heading key departments/functions.

- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities - A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Elite Pharmaceuticals Inc (Elite) is a specialty pharmaceutical company focuses on the development of oral sustained and controlled release drug products. The company manufactures and develops generic drugs with Abbreviated New Drug Applications (ANDA) and branded drugs with New Drug Application (NDA) for the treatment of pain, obesity, hypertension, depression, infection and allergy, among others. Elite also has a pipeline of abuse-deterrent opioids for the treatment of chronic pain. The company uses its proprietary ART (abuse-deterrent technology) platform to develop and manufacture oral, controlled-release drugs. Elite is headquartered in Northvale, New Jersey, the US.

Elite Pharmaceuticals Inc Key Recent Developments

Aug 09,2018: Elite Pharmaceuticals reports financial results for the first quarter of fiscal year 2019 ended June 30, 2018

Aug 07,2018: Elite Pharmaceuticals appoints Aqeel A. Fatmi to its Board of Directors

Jun 14,2018: Elite Pharmaceuticals Announces Financial Results for the Fiscal Year Ended March 31, 2018

Feb 09,2018: Elite Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2018 Ended December 31, 2017

Jan 10,2018: Elite Pharmaceuticals Reports Positive Topline Results from Pivotal Bioequivalence Studies for an Extended-Release Generic

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 - About the Company 6

Elite Pharmaceuticals Inc - Key Facts 6

Elite Pharmaceuticals Inc - Key Employees 7

Elite Pharmaceuticals Inc - Key Employee Biographies 8

Elite Pharmaceuticals Inc - Major Products and Services 9

Elite Pharmaceuticals Inc - History 11

Elite Pharmaceuticals Inc - Company Statement 14

Elite Pharmaceuticals Inc - Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Section 2 - Company Analysis 16

Company Overview 16

Elite Pharmaceuticals Inc - Business Description 17

Business Segment: Branded Pharmaceuticals (NDA segment) 17

Overview 17

Performance 17

Business Segment: Generic Pharmaceuticals (ANDA segment) 17

Overview 17

Performance 17

R&D Overview 17

Elite Pharmaceuticals Inc - Corporate Strategy 19

Elite Pharmaceuticals Inc - SWOT Analysis 20

SWOT Analysis - Overview 20

Elite Pharmaceuticals Inc - Strengths 20

Elite Pharmaceuticals Inc - Weaknesses 21

Elite Pharmaceuticals Inc - Opportunities 22

Elite Pharmaceuticals Inc - Threats 23

Elite Pharmaceuticals Inc - Key Competitors 24

Section 3 - Company Financial Ratios 25

Financial Ratios - Capital Market Ratios 25

Financial Ratios - Annual Ratios 26

Performance Chart 29

Financial Performance 29

Financial Ratios - Interim Ratios 30

Financial Ratios - Ratio Charts 31

Section 4 - Company's Lifesciences Financial Deals and Alliances 32

Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32

Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 33

Elite Pharmaceuticals Inc, Recent Deals Summary 34

Section 5 - Company's Recent Developments 35

Aug 09, 2018: Elite Pharmaceuticals reports financial results for the first quarter of fiscal year 2019 ended June 30, 2018 35

Aug 09, 2018: Elite Pharmaceuticals reports financial results for the first quarter of fiscal year 2019 ended June 30, 2018 36

Aug 09, 2018: Elite Pharmaceuticals reports financial results for the first quarter of fiscal year 2019 ended June 30, 2018 37

Aug 09, 2018: Elite Pharmaceuticals reports financial results for the first quarter of fiscal year 2019 ended June 30, 2018 38

Aug 09, 2018: Elite Pharmaceuticals reports financial results for the first quarter of fiscal year 2019 ended June 30, 2018 39

Aug 07, 2018: Elite Pharmaceuticals appoints Aqeel A. Fatmi to its Board of Directors 40

Aug 07, 2018: Elite Pharmaceuticals appoints Aqeel A. Fatmi to its Board of Directors 41

Aug 07, 2018: Elite Pharmaceuticals appoints Aqeel A. Fatmi to its Board of Directors 42

Feb 09, 2018: Elite Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2018 Ended December 31, 2017 43

Jan 10, 2018: Elite Pharmaceuticals Reports Positive Topline Results from Pivotal Bioequivalence Studies for an Extended-Release Generic 44

Section 6 - Appendix 45

Methodology 45

Ratio Definitions 45

About GlobalData 49

Contact Us 49

Disclaimer 49


List Of Figure

List of Figures

Elite Pharmaceuticals Inc, Performance Chart (2014 - 2018) 29

Elite Pharmaceuticals Inc, Ratio Charts 31

Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32

Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 33


List Of Table

List of Tables

Elite Pharmaceuticals Inc, Key Facts 6

Elite Pharmaceuticals Inc, Key Employees 7

Elite Pharmaceuticals Inc, Key Employee Biographies 8

Elite Pharmaceuticals Inc, Major Products and Services 9

Elite Pharmaceuticals Inc, History 11

Elite Pharmaceuticals Inc, Subsidiaries 15

Elite Pharmaceuticals Inc, Key Competitors 24

Elite Pharmaceuticals Inc, Ratios based on current share price 25

Elite Pharmaceuticals Inc, Annual Ratios 26

Elite Pharmaceuticals Inc, Annual Ratios (Cont...1) 27

Elite Pharmaceuticals Inc, Annual Ratios (Cont...2) 28

Elite Pharmaceuticals Inc, Interim Ratios 30

Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32

Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 33

Elite Pharmaceuticals Inc, Recent Deals Summary 34

Currency Codes 45

Capital Market Ratios 45

Equity Ratios 46

Profitability Ratios 46

Cost Ratios 47

Liquidity Ratios 47

Leverage Ratios 48

Efficiency Ratios 48

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Elite Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Sandoz Inc

Purdue Pharma LP

Par Pharmaceutical Holdings Inc

Pain Therapeutics Inc

Mylan Laboratories Ltd

DURECT Corp

Collegium Pharmaceutical Inc

Allergan Plc

Acura Pharmaceuticals Inc